These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 3240626)

  • 1. [Somatostatin and substance P in the cerebrospinal fluid in various neurological diseases].
    Harigaya Y; Shoji M; Hirai S; Wakabayashi K
    Rinsho Shinkeigaku; 1988 Aug; 28(8):891-6. PubMed ID: 3240626
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's disease and benign essential tremor: somatostatin-like immunoreactivity in the cerebrospinal fluid.
    Christensen SE; Dupont E; Mondrup K; Olivarius BF; Orskov H
    Adv Neurol; 1984; 40():325-31. PubMed ID: 6229980
    [No Abstract]   [Full Text] [Related]  

  • 3. A significant reduction of putative transmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease and spinocerebellar degeneration.
    Tohgi H; Abe T; Hashiguchi K; Takahashi S; Nozaki Y; Kikuchi T
    Neurosci Lett; 1991 May; 126(2):155-8. PubMed ID: 1681472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid corticotropin-releasing hormone in neurodegenerative diseases: reduction in spinocerebellar degeneration.
    Suemaru S; Suemaru K; Kawai K; Miyata S; Nobukuni K; Ihara Y; Namba R; Urakami K; Hashimoto K
    Life Sci; 1995; 57(24):2231-5. PubMed ID: 7475976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinico-pathological study of the central autonomic nervous system in idiopathic parkinsonism--in comparison with sporadic olivopontocerebellar atrophy].
    Mitake S; Mizutani T
    Rinsho Shinkeigaku; 1987 Apr; 27(4):472-8. PubMed ID: 3476231
    [No Abstract]   [Full Text] [Related]  

  • 6. [Velopharyngeal closure dysfunction in various neurological disorders examined by using the flow-nasality graph].
    Takizawa S; Yoshii F; Shinohara Y
    Rinsho Shinkeigaku; 1987 Sep; 27(9):1133-40. PubMed ID: 3481566
    [No Abstract]   [Full Text] [Related]  

  • 7. [Factors related to subjective QOL of patients with chronic neurological intractable diseases].
    Ogata Y; Iizuka T; Fukuhisa Y; Minowa M; Fujita T
    Nihon Koshu Eisei Zasshi; 1999 Aug; 46(8):650-7. PubMed ID: 10496034
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of acetylcholine concentration in cerebrospinal fluid of patients with neurologic diseases.
    Yamada H; Otsuka M; Fujimoto K; Kawashima K; Yoshida M
    Acta Neurol Scand; 1996 Jan; 93(1):76-8. PubMed ID: 8825278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Homovanillic acid in the cerebrospinal fluid: studies in Parkinson's syndrome and other diseases of the CNS].
    Bernheimer H; Birkmayer W; Hornykiewicz O
    Wien Klin Wochenschr; 1966 Jun; 78(23):417-9. PubMed ID: 4229554
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of anti-locus coeruleus immunoreactivity in CSF of patients with autonomic failure.
    Imrich R; Goldstein DS; Jacobowitz DM
    Clin Auton Res; 2006 Dec; 16(6):401-5. PubMed ID: 16977375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular somatostatin-like immunoreactivity in patients with basal ganglia disease.
    Cramer H; Wolf A; Rissler K; Weigel K; Ostertag C
    J Neurol; 1985; 232(4):219-22. PubMed ID: 2864402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lewy bodies in the visceral autonomic nervous system in Parkinson's disease.
    Wakabayashi K; Takahashi H; Ohama E; Takeda S; Ikuta F
    Adv Neurol; 1993; 60():609-12. PubMed ID: 8420198
    [No Abstract]   [Full Text] [Related]  

  • 13. Transport and production of cerebrospinal fluid (CSF) change in aging humans under normal and diseased conditions.
    Kleine TO; Hackler R; Lütcke A; Dauch W; Zöfel P
    Z Gerontol; 1993; 26(4):251-5. PubMed ID: 8212795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease.
    Tokuda T; Salem SA; Allsop D; Mizuno T; Nakagawa M; Qureshi MM; Locascio JJ; Schlossmacher MG; El-Agnaf OM
    Biochem Biophys Res Commun; 2006 Oct; 349(1):162-6. PubMed ID: 16930553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin in cerebrospinal fluid.
    Cooper PE
    Bull Clin Neurosci; 1985; 50():26-9. PubMed ID: 2876739
    [No Abstract]   [Full Text] [Related]  

  • 17. Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease.
    Isobe C; Murata T; Sato C; Terayama Y
    Life Sci; 2005 Aug; 77(15):1836-43. PubMed ID: 15935398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
    Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ventricular fluid pressure and the concentration of homovanillic acid in different parts of the cerebrospinal fluid system in patients with Parkinson's disease.
    West KA; Roos BE
    Confin Neurol; 1972; 34(2):136-42. PubMed ID: 4579783
    [No Abstract]   [Full Text] [Related]  

  • 20. The ventricular fluid pressure and the concentration of homovanillic acid in different parts of the cerebrospinal fluid system in patients with Parkinson's disease.
    West KA; Roos BE
    Confin Neurol; 1972; 34(1):136-42. PubMed ID: 4538913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.